$152,706 - 173,426 yearly
Number of Applicants
:000+
Let AI Supercharge Your Job Hunt!
JobCopilot scans 500,000+ company career sites daily to find jobs for you
Company Overview
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.
Position Overview
We are seeking a highly motivated and experienced Manager of CMC Stability Management and Analysis to join our team. This individual will lead the implementation and management of small molecule CMC stability programs at Immunome, for varegacestat, our lead compound nearing NDA submission. This individual will also perform statistical analysis, trending analysis as well as managing stability database. The incumbent will interpret and present stability data to all stake holder on a routine basis.
Responsibilities
Qualifications
Knowledge and Skills
Washington State Pay Range
$152,706 - $173,426 USD
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Auto-Apply to Manager, CMC Stability Management and Analysis Jobs with your AI JobCopilot
Copyright © 2026 Grabjobs Pte.Ltd. All Rights Reserved.